Skip to content

Effect of therapy on residual beta cell function in type-1 diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN70703138
Enrollment
Unknown
Registered
2002-10-03
Start date
2003-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes mellitus Nutritional, Metabolic, Endocrine Diabetes mellitus

Interventions

Conventional or intensive insulin therapy

Sponsors

Justus Liebig University (Germany)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Men or women aged 18 - 40 years at diagnosis 2. Established Type-1 Diabetes diagnosed up to three months ago 3. Consent to participate in a diabetes training programme 4. Informed consent before enrolment

Exclusion criteria

Exclusion criteria: 1. History of neuropathy, nephropathy, and retinopathy of other than diabetes related origin 2. Negative C-peptide level at diagnosis 3. History of psychiatric disease or drug or alc ohol abuse 4. Treatment with oral antidiabetic medication 5. Subject unlikely to comply with the protocol (e.g. inability or unwillingness to participate adequate training or to complete diaries appropriately) or to understand the nature and the scope of the study

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026